REFLECTIONS FROM A SENIOR INVESTIGATOR
Clinical trial to try to diagnose pregnancy as soon as four days after embryo transfer
Shortening detection of pregnancy period with a different isoform of hCG, called hypoglicosylated hCG.
Population aging is the big problem from this century in terms of fertility specially for women. We try to fight this problem either by fertility preservation (oocyte vitrification) or ovarion rejuvenation.
PGS and Mosaicism: what does the future hold?
Now have a great command of PGS technology, for that reason we are able to move forward and provide more detailed and more prognostic assessment about embryos, we are improving outcomes for our patients, reducing losses and getting better pregnancy rates.
Collaboration between our research and our daily clinical practice in IVIRMA
Research is one the IVIRMA values. We continuously try to find and develop new technologies to be applied in the daily practices with our patients.
Individualisation and patient tailored approach, getting ways of following ‘Dogmas’
Individualisation is only possible through further research. When we speak about individualisation it needs to be according to every patient’s requirement.
The desire to investigate the effect of geometrical parameters of infertility
The desire, opportunity, and resources to investigate the effect of geographical, genetic and cultural parameters of infertility.
Oocyte cryopreservation: transition from experimental to mainstream
Fertiliy preservation is today a reality thanks to vitrification. Cryopreservation is a fundamental tool in reproductive medicine. This is a discipline which brings women the opportunity to save the fertility for the future.
Today at the time that women live longer and delay parenthood without a tangible change in the time of their reproductive aging, assisted reproduction becomes their hope.